Capital of Life at Nordic Life Science Days: Spotlight on Stockholm–Uppsala

Earlier this year, Region Stockholm and Region Uppsala adopted a joint life science strategy. The strategy brings together stakeholders from academia, business, healthcare and the public sector, united by a shared ambition: to develop Stockholm–Uppsala into one of the world’s leading life science clusters.

Within the strategy is the Capital of Life initiative, that brings together all stakeholders and supporting organizations to contribute to its implementation through long-term, strategic collaboration. At this year’s Nordic Life Science Days, the initiative came together to showcase the region’s strengths, highlight central questions for continued development, and engage with the national and international life science community.

“Together, we are strong. Nordic Life Science Days was a fantastic opportunity for all of us to come together and showcase the initiative and what makes Stockholm–Uppsala unique. Flemingsberg is an important part of Capital of Life. Here, research, healthcare, companies, and research infrastructure are closely located. My role is to connect companies with the right expertise, infrastructure, and partners so that they can develop and grow.” says Natasha Bank, Cluster Manager at Flemingsberg Science, who participated in the Capital of Life booth at Kistamässan.

During the conference, conversations and discussions focused on how the regions can continue to strengthen their position in life science together – from research and innovation to establishments, investment and international competitiveness. Presentations and discussions were also held in the joint booth and on stage, bringing together companies, researchers, investors, and other ecosystem stakeholders. Among the topics discussed were ATMP as area of strength, health data and precision medicine, as well as the medtech ecosystem.

Flemingsberg Science Foundation has, through Huddinge Municipality’s engagement in the strategy, been involved in the work from start.

“We are already underway with several important initatives to help put the strategy into practice. Through our Establisment Office and and the Life Science Cluster Flemingsberg project, we are creating attractive innovation environments and meeting places, marketing, and actively working to attract new life science companies to establish themselves, says Johnny Högberg, CEO of Flemingsberg Science.

Read more about Capital of Life and the joint Stockholm–Uppsala life science strategy here.

In the video below you can hear Pontus Holm, Life Science Program Coordinator at Region Stockholm, explaining the strategy and Capital of Life.

Limitless Potential: Winner of the Flemingsberg Science Award 2025

Young people in disadvantaged areas often face mental health challenges and a lack of support, which can lead to isolation and destructive choices. Limitless Potential, winner of the Flemingsberg Science Award IDEA 2025, has created a safe space where creativity and social entrepreneurship come together to support youth.

50 years of life-changing therapies

On November 12 1975, the first allogeneic bone marrrow transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.

Go to Top